Human medicines European public assessment report (EPAR): Odomzo, sonidegib, Carcinoma, Basal Cell, Date of authorisation: 14/08/2015, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Aldara, imiquimod, Condylomata Acuminata,Keratosis,Keratosis, Actinic,Carcinoma, Basal Cell, Date of authorisation: 18/09/1998, Revision: 25, Status: Authorised

Case Medical Research ◽

10.31525/cmr-91357f ◽

2019 ◽

Author(s):

Keyword(s):

Basal Cell ◽

Condylomata Acuminata ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Odomzo, sonidegib, Carcinoma, Basal Cell, Date of authorisation: 14/08/2015, Revision: 6, Status: Authorised

Case Medical Research ◽

10.31525/cmr-6a72a1 ◽

2018 ◽

Author(s):

Keyword(s):

Basal Cell ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Aldara, imiquimod, Condylomata Acuminata,Keratosis,Keratosis, Actinic,Carcinoma, Basal Cell, Date of authorisation: 18/09/1998, Revision: 25, Status: Authorised

Case Medical Research ◽

10.31525/cmr-908f24 ◽

2019 ◽

Author(s):

Keyword(s):

Basal Cell ◽

Condylomata Acuminata ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Erivedge, vismodegib, Carcinoma, Basal Cell, Date of authorisation: 12/07/2013, Date of refusal: 26/04/2013, Revision: 11, Status: Authorised

Case Medical Research ◽

10.31525/cmr-b1a4be ◽

2019 ◽

Cited By ~ 1

Author(s):

Keyword(s):

Basal Cell ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Ameluz, 5-aminolevulinic acid hydrochloride, Keratosis, Actinic,Carcinoma, Basal Cell, Date of authorisation: 13/12/2011, Revision: 13, Status: Authorised

Case Medical Research ◽

10.31525/cmr-b32205 ◽

2019 ◽

Author(s):

Keyword(s):

Basal Cell ◽

Aminolevulinic Acid ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Acid Hydrochloride

Download Full-text

Human medicines European public assessment report (EPAR): Ameluz, 5-aminolevulinic acid hydrochloride, Keratosis, Actinic,Carcinoma, Basal Cell, Date of authorisation: 13/12/2011, Revision: 14, Status: Authorised

Case Medical Research ◽

10.31525/cmr-b2f85e ◽

2019 ◽

Author(s):

Keyword(s):

Basal Cell ◽

Aminolevulinic Acid ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Acid Hydrochloride

Download Full-text

Human medicines European public assessment report (EPAR): Erivedge, vismodegib, Carcinoma, Basal Cell, Date of authorisation: 12/07/2013, Date of refusal: 26/04/2013, Revision: 11, Status: Authorised

Case Medical Research ◽

10.31525/cmr-b1ce6a ◽

2019 ◽

Author(s):

Keyword(s):

Basal Cell ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Fabrazyme, agalsidase beta, Fabry Disease, Date of authorisation: 03/08/2001, Revision: 26, Status: Authorised

Case Medical Research ◽

10.31525/cmr-19715f1 ◽

2019 ◽

Author(s):

Keyword(s):

Fabry Disease ◽

Agalsidase Beta ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Controloc Control, pantoprazole, Gastroesophageal Reflux, Date of authorisation: 11/06/2009, Revision: 11, Status: Authorised

Case Medical Research ◽

10.31525/cmr-193042d ◽

2019 ◽

Author(s):

Keyword(s):

Gastroesophageal Reflux ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Striascan, ioflupane (123i), Radionuclide Imaging,Dementia,Movement Disorders, Date of authorisation: 25/06/2019

Case Medical Research ◽

10.31525/cmr-193042a ◽

2019 ◽

Author(s):

Keyword(s):

Radionuclide Imaging ◽

Movement Disorders ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text